Joe Jimenez News
Most Popular Joe Jimenez Story
Jimenez counts on 7 drugs to take Novartis past Diovan
Maybe it's the rarefied Davos air or the long-range mountain views, but Novartis ($NVS) CEO Joe Jimenez is feeling optimistic about the post-Diovan future. After the Swiss drugmaker loses patent Read more...
Latest Headlines
- February 9, 2012
- January 27, 2012
- January 17, 2012
- November 29, 2011
- November 17, 2011
- November 16, 2011
- October 25, 2011
- October 10, 2011
- September 15, 2011
- September 2, 2011
- July 19, 2011
- July 11, 2011
- June 7, 2011
- June 1, 2011
- April 4, 2011
- January 31, 2011
- November 16, 2010
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
